Tabasco did not simply win market share. It secured a place on the table.
That distinction matters for both marketing and HR. The company behind Tabasco employs roughly 250 people yet sells in more than 160 countries. My latest paper argues that this extraordinary reach comes from combining distinctive product physics with ownership of a highly defensible consumption occasion.
A serving is only a few drops, so one bottle provides hundreds of uses. The sauce remains stable for years, requires no cold chain and can travel almost anywhere at a negligible freight cost per serving. I call this characteristic “serving density.”
But serving density explains reach, not competitive protection. Tabasco’s deeper marketing advantage is the slot it occupies. Restaurants do not reconsider the hot-sauce category every morning. The familiar bottle sits on the table and is reordered through habit. Brand, trademark protection and more than 150 years of incumbency make that position extremely difficult to dislodge.
Sriracha shows the boundary. It has similar product physics and has reached dozens of countries, but the category name was not protected and competitors entered the same space. Dosage created reach, but it did not create the same lock.
The HR implications follow directly. When the product carries much of the distribution burden, growth does not require a large workforce in every country. Talent can remain concentrated around the capabilities that protect the model: product quality, brand stewardship, distributor relationships and disciplined execution. One international manager can cover territory that might require entire country organizations in another business.
This changes the central growth question. Marketing leaders should ask whether the brand can own a repeated consumption occasion, not simply attract attention. HR leaders should ask which few roles protect that advantage, not automatically replicate a conventional multinational structure.
The product gets you onto the table. The brand keeps you there. The organization should be built around protecting both.
Read the full article "Three Drops: How Dosage, Not Scale, Buys Global Reach" here.